Holen Sie sich die Stockscreener-App
36.00
5.46%
-2.08
Handel nachbörslich:
36.25
0.25
+0.69%
Schlusskurs vom Vortag:
$38.08
Offen:
$38.11
24-Stunden-Volumen:
3.89M
Relative Volume:
0.61
Marktkapitalisierung:
$4.05B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-99.15M
KGV:
-38.71
EPS:
-0.93
Netto-Cashflow:
$-74.25M
1W Leistung:
+0.19%
1M Leistung:
+21.13%
6M Leistung:
+22.62%
1J Leistung:
-50.60%
1-Tages-Spanne:
$35.51
$38.72
1-Wochen-Bereich:
$34.61
$39.57
52-Wochen-Spanne:
$18.92
$79.10
Viking Therapeutics Inc Stock (VKTX) Company Profile
Firmenname
Viking Therapeutics Inc
Sektor
Branche
Telefon
858-704-4660
Adresse
9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA
Vergleichen Sie VKTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VKTX
Viking Therapeutics Inc
|
36.00 | 4.30B | 0 | -99.15M | -74.25M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-29 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-08 | Eingeleitet | Goldman | Neutral |
| 2025-02-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-02-07 | Eingeleitet | Citigroup | Neutral |
| 2024-12-02 | Eingeleitet | Piper Sandler | Overweight |
| 2024-11-22 | Eingeleitet | B. Riley Securities | Buy |
| 2024-11-04 | Bestätigt | H.C. Wainwright | Buy |
| 2024-09-11 | Eingeleitet | JP Morgan | Overweight |
| 2024-06-27 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-05-16 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-03-26 | Bestätigt | Oppenheimer | Outperform |
| 2024-03-07 | Eingeleitet | Jefferies | Buy |
| 2024-02-28 | Bestätigt | Oppenheimer | Outperform |
| 2023-05-31 | Fortgesetzt | ROTH MKM | Buy |
| 2023-03-28 | Bestätigt | Maxim Group | Buy |
| 2023-03-17 | Eingeleitet | Stifel | Buy |
| 2021-07-29 | Fortgesetzt | BTIG Research | Buy |
| 2021-05-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-06-05 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-05-05 | Eingeleitet | Chardan Capital Markets | Buy |
| 2020-05-01 | Eingeleitet | BTIG Research | Buy |
| 2019-07-16 | Eingeleitet | Oppenheimer | Outperform |
| 2019-06-25 | Eingeleitet | Stifel | Buy |
| 2019-03-29 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-03-14 | Bestätigt | Maxim Group | Buy |
| 2019-02-22 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2018-12-12 | Eingeleitet | B. Riley FBR | Buy |
| 2018-11-19 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-09-18 | Bestätigt | H.C. Wainwright | Buy |
| 2018-09-18 | Bestätigt | Maxim Group | Buy |
| 2018-09-18 | Bestätigt | Raymond James | Outperform |
| 2018-07-20 | Eingeleitet | SunTrust | Buy |
| 2018-06-28 | Eingeleitet | Raymond James | Outperform |
| 2018-06-01 | Bestätigt | Laidlaw | Buy |
| 2018-05-31 | Bestätigt | Maxim Group | Buy |
| 2018-03-26 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-11-28 | Bestätigt | Maxim Group | Buy |
| 2017-11-21 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Viking Therapeutics Inc Aktie (VKTX) Neueste Nachrichten
Why Viking Therapeutics Inc. stock could benefit from AI revolution2025 Volume Leaders & AI Driven Stock Movement Reports - newser.com
Signal strength of Viking Therapeutics Inc. stock in tech scannersJuly 2025 Spike Watch & High Return Trade Opportunity Guides - newser.com
Acquisition Buzz Intensifies Around Viking Therapeutics Stock - AD HOC NEWS
Viking Therapeutics Could Be Pharma’s Next Big Buyout Target - AOL.com
How Viking Therapeutics Inc. (1VT) stock reacts to stronger dollarQuarterly Profit Review & Risk Adjusted Buy and Sell Alerts - newser.com
Will Viking Therapeutics Inc. stock outperform Dow Jones indexMarket Performance Report & Free Fast Entry Momentum Trade Alerts - newser.com
Why Viking Therapeutics Inc. stock attracts high net worth investors2025 Buyback Activity & Expert Approved Trade Ideas - newser.com
Why Viking Therapeutics Inc. stock could see breakout soonTake Profit & Fast Exit/Entry Strategy Plans - newser.com
Can Viking Therapeutics Inc. stock hit record highs againMarket Trend Summary & Growth Focused Entry Reports - newser.com
Is Viking Therapeutics Inc. stock a buy before product launchesIndex Update & Fast Momentum Entry Tips - newser.com
Prediction: The Next Eli Lilly Might Already Be Trading Under $50 - AOL.com
Advanced analytics toolkit walkthrough for Viking Therapeutics Inc.2025 Earnings Impact & Step-by-Step Trade Execution Guides - newser.com
Viking Therapeutics: A Tale of Financial Setback and Clinical Promise - AD HOC NEWS
Viking Therapeutics, Inc. (NASDAQ:VKTX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
How Viking Therapeutics Inc. stock trades during market volatility2025 Price Action Summary & High Return Trade Guides - newser.com
Heatmap analysis for Viking Therapeutics Inc. and competitorsQuarterly Trade Report & Smart Swing Trading Techniques - newser.com
Sell Novo Nordisk And Buy Viking Therapeutics (NASDAQ:VKTX) - Seeking Alpha
Can trapped investors hope for a rebound in Viking Therapeutics Inc.July 2025 Trade Ideas & AI Enhanced Execution Alerts - newser.com
My Top Growth Stock to Buy in November - AOL.com
Viking Therapeutics (VKTX): Assessing Valuation After Shares Jump 28% in the Past Month - Yahoo Finance
Is Viking Therapeutics Inc. (1VT) stock undervalued by metricsJuly 2025 Decliners & Long-Term Growth Plans - newser.com
How Viking Therapeutics Inc. (1VT) stock trades after earningsWatch List & Entry Point Confirmation Signals - newser.com
Should You Buy Viking Therapeutics Before Nov. 5? - The Globe and Mail
Should You Buy Viking Therapeutics Before Nov. 5? - The Motley Fool
Viking Therapeutics Stock Powers Toward Best Month Of The Year — Wall Street, Retail Bulls Fired Up On Obesity Drug Promise - Stocktwits
Is Viking Therapeutics Inc. forming a bottoming baseJuly 2025 Catalysts & Low Risk Growth Stock Ideas - newser.com
How hedge fund analytics apply to Viking Therapeutics Inc. stock2025 Winners & Losers & Real-Time Buy Signal Alerts - newser.com
Viking Therapeutics (VKTX) Gets a Buy from BTIG - The Globe and Mail
Daymark Wealth Partners LLC Takes $212,000 Position in Viking Therapeutics, Inc. $VKTX - MarketBeat
What makes Viking Therapeutics Inc. stock attractive to growth fundsWeekly Risk Report & Free AI Powered Buy and Sell Recommendations - newser.com
Viking Therapeutics (NASDAQ:VKTX) Trading 6.8% HigherShould You Buy? - MarketBeat
Canaccord Genuity Group Initiates Coverage on Viking Therapeutics (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics (VKTX): Assessing Valuation as VK2735 Clinical Updates Fuel Investor Interest - simplywall.st
Live market analysis of Viking Therapeutics Inc.Portfolio Return Summary & Verified Swing Trading Watchlists - newser.com
Can Viking Therapeutics Inc. (1VT) stock sustain margin levelsEarnings Performance Report & Low Risk Entry Point Tips - newser.com
3 Promising Growth Stocks That Are Down Around 60% From Their Highs - The Motley Fool
Finanzdaten der Viking Therapeutics Inc-Aktie (VKTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):